# ContextOps Validation Report

## Validation Target

- Artifact: `zelostat-marktanalyse-context-packet-v0-2.md`
- Version: 0.2
- Producer: `marktanalyse`
- Intended consumers: `buying-contexts`, `segmentation-strategy`
- Revision attempt: 1 of maximum 2

## Applied Contracts And Profiles

- Universal ContextOps Handoff Contract
- Primary profile: Market Context
- Evidence and provenance rules
- Regulated/sensitive claim-risk overlay
- B2B professional-consumable lens
- Downstream handoff usability and leakage checks

## Verdict

PASS

## Findings

| ID | State | Severity | Category | Location | Evidence | Required correction | Owner |
|---|---|---|---|---|---|---|---|
| EVD-01 | persistent | minor | Evidence, provenance, citation, or uncertainty | `Market Boundary` core-market row; `Competitor And Substitute Clusters` standard-needle row | Claim-level source mapping was added and unsupported named-device and compatibility details were removed. However, the supplied upstream summaries and extract do not preserve the exact TSK `33G` LDS evidence or the stated PRE `30G, 32G, and 33G` range. The confirmed 35G direct competitor remains sufficiently supported for safe handoff. | Verify the exact gauges against a preserved source extract, or generalize these references to the supported broader fine-gauge/LDS range. | producer |
| EVD-02 | resolved | major | Evidence, provenance, citation, or uncertainty | `Minimal Market Dynamics` | Category observations are now separated from adoption and procurement hypotheses. Relevance to Zelostat purchasing and switching is explicitly unverified. | None. Preserve this distinction. | producer |
| CLM-01 | resolved | major | Claim risk or allowed use | `Business-Model Lens`; `Regulated And Sensitive Claim-Risk Overlay` | Regulatory identity is explicitly unconfirmed. Savings, flow, geometric, comfort, bruising and adverse-event claims are atomic, risk-classified and restricted by allowed use. Evidence requests are concrete. | None. Preserve the current restrictions. | producer |
| CTR-01 | resolved | minor | Contract or required structure | `Scope Boundary` → `Produces` | The packet now explicitly inventories the fields handed to downstream consumers. | None. | producer |
| EVD-03 | resolved | minor | Evidence, provenance, citation, or uncertainty | `Working Market Definition`; `Context Packet Summary` | Germany is clearly identified as the evidenced starting geography. Europe/EU/EEA is consistently labeled exploratory pending commercial, intended-use and regulatory verification. | None. | producer |

## Passed Checks

- All five stable findings were tested before new-defect review.
- No stable finding regressed or was superseded.
- No critical or major defect remains.
- Purpose, stage, scope, consumes and produces fields are explicit.
- Core, adjacent, extended and excluded market boundaries remain usable.
- A confirmed 35G LDS direct competitor is supported.
- Standard, system, adjacent-device and status-quo alternatives remain distinct.
- Observed facts are separated from purchasing and adoption hypotheses.
- Sensitive manufacturer claims are not promoted as independent proof.
- Regulatory identity and conformity are not inferred from the sales context.
- Dynamic German distribution evidence remains dated.
- The catalogue discrepancy remains visible.
- No segment priority, positioning, campaign, content, SEO/GEO, sales, lifecycle or GTM recommendation was introduced.
- Buying-context questions preserve roles, triggers, comparison units, proof needs and observable signals.
- Segmentation questions preserve multiple possible bases without choosing one.
- Downstream agents can continue without inventing the essential market boundary or alternative set.

## Missing Inputs Or Decisions

The following remain evidence gaps but do not prevent safe handoff:

- Preserved evidence for the exact TSK gauge listings noted in EVD-01.
- IFU, label, declaration of conformity and intended-use documentation.
- Confirmed legal manufacturer and economic-operator roles.
- Current product master resolving the 25G catalogue discrepancy.
- Independent residual-volume and flow testing.
- Clinical evidence for comfort, bruising and adverse-event claims.
- Customer or procurement evidence about switching criteria.
- Verified geographic coverage outside Germany.

## Revision Instructions

No mandatory revision is required before downstream use.

If the producer issues another version, correct only the minor gauge-level provenance issue in EVD-01. Preserve the current scope boundaries, claim restrictions, hypothesis labels, geographic distinction and downstream-neutral questions.

## Revalidation Scope

The artifact may advance to `buying-contexts` and `segmentation-strategy`.

Revalidation is only necessary if:

- EVD-01 is corrected in a later version;
- market boundaries or competitor clusters materially change;
- regulatory or clinical evidence is added;
- sensitive claims receive broader allowed use; or
- downstream recommendations are introduced.

## Learning Signal

Case-specific signal: direct URL attribution does not fully replace a preserved extract when exact product variants materially affect a competitor claim. This remaining issue is minor and does not justify a profile or system-wide change.
